Found: 8
Select item for more details and to access through your institution.
Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073464
- By:
- Publication type:
- Article
c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27.
- Published in:
- Journal of Cellular Biochemistry, 2008, v. 104, n. 6, p. 2091, doi. 10.1002/jcb.21765
- By:
- Publication type:
- Article
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.
- Published in:
- Nature Cell Biology, 2007, v. 9, n. 4, p. 470, doi. 10.1038/ncb1559
- By:
- Publication type:
- Article
miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Identification of genes potentially involved in the acquisition of androgen?independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
- Published in:
- Prostate, 2007, v. 67, n. 1, p. 83, doi. 10.1002/pros.20505
- By:
- Publication type:
- Article
A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 4, p. 536, doi. 10.3390/pharmaceutics16040536
- By:
- Publication type:
- Article
Inhibition of RelB by 1,25-dihydroxyvitamin D<sub>3</sub> promotes sensitivity of breast cancer cells to radiation.
- Published in:
- Journal of Cellular Physiology, 2009, v. 220, n. 3, p. 593, doi. 10.1002/jcp.21765
- By:
- Publication type:
- Article
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-03024-3
- By:
- Publication type:
- Article